Should Investors Worry Over a Sluggish First Quarter for Vanda Pharmaceuticals?The Motley Fool • 05/09/19
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/02/19